Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Kullberg

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Nanomedicine|August 10, 2017
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCsAlexandra Francian, Kristine Mann, Max Kullberg
Nanomedicine : Nanotechnology, Biology, and Medicine|March 18, 2014
Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificityMax Kullberg, Ryan McCarthy, Thomas J Anchordoquy
Journal of Drug Targeting|December 18, 2008
A two-component drug delivery system using Her-2-targeting thermosensitive liposomesMax Kullberg, Kristine Mann, Jesse Lee Owens
Journal of Drug Targeting|March 6, 2010
Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomesMax Kullberg, Jesse Lee Owens, Kristine Mann
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 17, 2013
Systemic tumor-specific gene deliveryMax Kullberg, Ryan McCarthy, Thomas J Anchordoquy
Molecular Pharmaceutics|May 25, 2012
Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLOMax Kullberg, Kristine Mann, Thomas J Anchordoquy
Nanomedicine : Nanotechnology, Biology, and Medicine|April 4, 2015
Complement C3 mediated targeting of liposomes to granulocytic myeloid derived suppressor cellsMax Kullberg, Holly Martinson, Kristine Mann, et al.
Therapeutic Delivery|April 6, 2013
Cholesterol domains enhance transfectionJamie L Betker, Max Kullberg, Joe Gomez, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2018
Intratumoral delivery of antigen with complement C3-bound liposomes reduces tumor growth in miceAlexandra Francian, Shelby Namen, Madigan Stanley, et al.
Pharmaceutical Frontiers|December 31, 2019
Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of CancerMax Kullberg, Alexandra Francian, Ameneh Arabi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Nanomedicine|August 10, 2017
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCsAlexandra Francian, Kristine Mann, Max Kullberg
Nanomedicine : Nanotechnology, Biology, and Medicine|March 18, 2014
Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificityMax Kullberg, Ryan McCarthy, Thomas J Anchordoquy
Journal of Drug Targeting|December 18, 2008
A two-component drug delivery system using Her-2-targeting thermosensitive liposomesMax Kullberg, Kristine Mann, Jesse Lee Owens
Journal of Drug Targeting|March 6, 2010
Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomesMax Kullberg, Jesse Lee Owens, Kristine Mann
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 17, 2013
Systemic tumor-specific gene deliveryMax Kullberg, Ryan McCarthy, Thomas J Anchordoquy
Molecular Pharmaceutics|May 25, 2012
Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLOMax Kullberg, Kristine Mann, Thomas J Anchordoquy
Nanomedicine : Nanotechnology, Biology, and Medicine|April 4, 2015
Complement C3 mediated targeting of liposomes to granulocytic myeloid derived suppressor cellsMax Kullberg, Holly Martinson, Kristine Mann, et al.
Therapeutic Delivery|April 6, 2013
Cholesterol domains enhance transfectionJamie L Betker, Max Kullberg, Joe Gomez, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 13, 2018
Intratumoral delivery of antigen with complement C3-bound liposomes reduces tumor growth in miceAlexandra Francian, Shelby Namen, Madigan Stanley, et al.
Pharmaceutical Frontiers|December 31, 2019
Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of CancerMax Kullberg, Alexandra Francian, Ameneh Arabi, et al.
Pageof 2